Temporal and Spatial Evolution of Somatic Chromosomal Alterations: A Case-Cohort Study of Barrett's Esophagus
暂无分享,去创建一个
Carissa A. Sanchez | Xiaohong Li | Patricia L. Blount | Mary K Kuhner | Carlo C Maley | C. Maley | P. Blount | B. Reid | M. Kuhner | T. Vaughan | R. Odze | P. Galipeau | C. Sanchez | Xiaohong Li | T. Paulson | Rumen Kostadinov | C. Sather | Cassandra L Sather | Thomas L Vaughan | Robert D Odze | Jessica Arnaudo | Patricia C Galipeau | Carissa A Sanchez | Thomas G Paulson | Brian J Reid | Patricia L Blount | Jessica Arnaudo | Karen Liu | Rumen L Kostadinov | Steven G Self | Karen Liu | Steven G. Self
[1] Steven J. M. Jones,et al. Circos: an information aesthetic for comparative genomics. , 2009, Genome research.
[2] M. Feith,et al. Temporal Trends in Long-Term Survival and Cure Rates in Esophageal Cancer: A SEER Database Analysis , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[3] N. Seersholm,et al. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study , 1999, American Journal of Gastroenterology.
[4] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[5] J. Salk. Clonal evolution in cancer , 2010 .
[6] K. Gunderson,et al. Deletion at Fragile Sites Is a Common and Early Event in Barrett's Esophagus , 2010, Molecular Cancer Research.
[7] Gary Longton,et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.
[8] Kamran Ayub,et al. NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma , 2007, PLoS medicine.
[9] O. Yokosuka,et al. Abstract 4383: Targeting tumor microenvironment with gemcitabine is useful for the treatment of pancreatic ductal adenocarcinoma , 2012 .
[10] A. McKenna,et al. Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity , 2013, Nature Genetics.
[11] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[12] N. Pavelka,et al. Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer. , 2010, Current opinion in cell biology.
[13] Xiaohong Li,et al. Direct Inference of SNP Heterozygosity Rates and Resolution of LOH Detection , 2007, PLoS Comput. Biol..
[14] H. Welch,et al. Overdiagnosis in cancer. , 2010, Journal of the National Cancer Institute.
[15] Sonika Tyagi,et al. Whole Genome Expression Array Profiling Highlights Differences in Mucosal Defense Genes in Barrett's Esophagus and Esophageal Adenocarcinoma , 2011, PloS one.
[16] Carissa A. Sanchez,et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma , 2006, Nature Genetics.
[17] J. Marioni,et al. Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma , 2011, Gut.
[18] Steven G. Self,et al. Asymptotic Distribution Theory and Efficiency Results for Case-Cohort Studies , 1988 .
[19] J. Goldblum,et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. , 1998, The Annals of thoracic surgery.
[20] Yuchen Jiao,et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. , 2012, Cancer discovery.
[21] A. Sivachenko,et al. Punctuated Evolution of Prostate Cancer Genomes , 2013, Cell.
[22] J. Goldblum,et al. Intramucosal esophageal adenocarcinoma: primum non nocere. , 2013, The Journal of thoracic and cardiovascular surgery.
[23] A. Sonnenberg,et al. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma , 2002, American Journal of Gastroenterology.
[24] Brian J. Reid,et al. Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus , 2000 .
[25] R. L. Prentice,et al. A case-cohort design for epidemiologic cohort studies and disease prevention trials , 1986 .
[26] G. Tytgat,et al. Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma , 1998, Gut.
[27] Brian Reid,et al. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. , 2013, JAMA.
[28] Wei Zhao,et al. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. , 2013, Gastroenterology.
[29] Patricia L. Blount,et al. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.
[30] A. Sonnenberg,et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.
[31] A. Wicks,et al. Ten years’ experience of screening patients with Barrett’s oesophagus in a university teaching hospital , 1997, Gut.
[32] B. Reid,et al. Progression to cancer in Barrett's esophagus is associated with genomic instability. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[33] Xiaohong Li,et al. Application of Biomarkers in Cancer Risk Management: Evaluation from Stochastic Clonal Evolutionary and Dynamic System Optimization Points of View , 2011, PLoS Comput. Biol..
[34] Prateek Sharma,et al. Long-term follow-up of Barrett's high-grade dysplasia , 2000, American Journal of Gastroenterology.
[35] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[36] A. McKenna,et al. Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.
[37] Carissa A. Sanchez,et al. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. , 2005, The Lancet. Oncology.
[38] Carissa A. Sanchez,et al. Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.
[39] N. Hayward,et al. Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. , 2008, Cancer research.
[40] Noel S Weiss,et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. , 2002, Gastroenterology.
[41] B. Reid,et al. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis , 2010, Nature Reviews Cancer.
[42] M. Meyerson,et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. , 2012, Cancer research.
[43] Patricia L. Blount,et al. Single Nucleotide Polymorphism–Based Genome-Wide Chromosome Copy Change, Loss of Heterozygosity, and Aneuploidy in Barrett's Esophagus Neoplastic Progression , 2008, Cancer Prevention Research.
[44] J. Troge,et al. Tumour evolution inferred by single-cell sequencing , 2011, Nature.
[45] J. Troge,et al. Inferring tumor progression from genomic heterogeneity. , 2010, Genome research.
[46] J. Reguła,et al. Molecular defense mechanisms of Barrett’s metaplasia estimated by an integrative genomics , 2007, Journal of Molecular Medicine.
[47] N. Carter,et al. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.
[48] David F Ransohoff,et al. Principles of cancer screening: lessons from history and study design issues. , 2010, Seminars in oncology.
[49] Xiaohong Li,et al. A Comprehensive Survey of Clonal Diversity Measures in Barrett's Esophagus as Biomarkers of Progression to Esophageal Adenocarcinoma , 2010, Cancer Prevention Research.
[50] Patricia L. Blount,et al. Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus , 2000, American Journal of Gastroenterology.
[51] Patrick O. Brown,et al. The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection , 2009, PLoS medicine.
[52] H. Welch,et al. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.
[53] H. Sørensen,et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. , 2011, The New England journal of medicine.
[54] B. Reid,et al. p53-mutant clones and field effects in Barrett's esophagus. , 1999, Cancer research.
[55] Martin A. Nowak,et al. The significance of unstable chromosomes in colorectal cancer , 2003, Nature Reviews Cancer.
[56] M. Nowak,et al. Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.
[57] E. Kuipers,et al. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[58] Kenneth K Wang,et al. Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.
[59] L. Cavalli-Sforza,et al. Multilocus genotypes, a tree of individuals, and human evolutionary history. , 1997, American journal of human genetics.
[60] Carissa A. Sanchez,et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[61] Kenneth K Wang,et al. Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis , 2010, Cancer Prevention Research.
[62] R. Odze. What the gastroenterologist needs to know about the histology of Barrett's esophagus , 2011, Current opinion in gastroenterology.
[63] C. Gutschow,et al. Prognostic impact of nodal micrometastasis in early esophageal cancer. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[64] David Pellman,et al. Causes and consequences of aneuploidy in cancer , 2012, Nature Reviews Genetics.
[65] Martin A. Nowak,et al. Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.
[66] Prateek Sharma,et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. , 2011, Gastroenterology.